XD Sitaili (603520)
SSE · 603520
Market Cap$4.3B
Revenue$2.5B
Employees1905
Listed OnSSE
Ticker603520
CEO / ExecMr. Weiyi Shen
HeadquartersTaizhou
MarketMainland China
Websitewww.starrypharm.com
Overview
Zhejiang Starry Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical raw materials in China and internationally. It operates through Contrast Agent Series, Quinolone Series, CMO/CDMO, and Others segments. The company offers preparation products comprising iohexol, iopamidol, iodixanol, iomeprol, ioversol, and gadobenate dimeglumine injections; contrast agent APIs and intermediates consisting of iohexol, iopamidol, i
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.